Moody’s affirms Aspirus Wausau Hospital’s ‘A1’ rating

Moody’s Investors Service affirmed the “A1” rating on Aspirus Wausau (Wis.) Hospital’s $170 million of rated revenue bonds.

Advertisement

The rating affirmation is based on Aspirus’ solid operating profitability, healthy liquidity position and strong leverage measures. The hospital also faces several challenges, including a competitive market.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that Aspirus will continue to generate solid margins.

More articles on healthcare finance:
How productivity improvements could help healthcare lower prices
VSS Medical Technologies expands with Legato acquisition: 5 things to know
Capital One launches new unitranche loan program

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.